Mankind Pharma Limited (INE634S01028) — research page
IN · in-cm-kg/XNSE/INE634S01028 · as of 2026-11-06
Identity and listing
The issuer is Mankind Pharma Limited, listed on the National Stock Exchange of India under ticker INE634S01028 and ISIN INE634S01028. The LEI, security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Mankind Pharma Limited | source · 2026-11-06 |
| exchange | National Stock Exchange of India | source · 2026-11-06 |
| ticker | INE634S01028 | source · 2026-11-06 |
| ISIN | INE634S01028 | source · 2026-11-06 |
| LEI | not on the record | |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 0 filings in the twelve months to 2026-11-06, on 0 filing days. The median gap between filing days is not on the record, and no latest filing date or filing type is on the record. The exchange peer set holds 2613 issuers, with a median cadence gap not on the record, a median of 0 filings and a median latency not on the record. The sector peer median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 0 | — | — |
| exchange median: National Stock Exchange of India (2613 issuers) | 0 | null | null |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record and its location are not on the record. Auditor changes are not on the record, as the lifecycle type map for this register is not yet in place.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the lifecycle type map for this register is not yet in place. The halt flag shows the issuer as listed, not halted.
Orderability
The outcome is ACM-200 for the accredited investor, Retail individual investor, Qualified Institutional Buyer and Non-Institutional Investors categories, each determinable. The rule version is acm-68000/in/sebi-suitability-sebi-investment-advisers-regulations-2013-r/r1, with the chapter as of 2026-11-04.
| client category | outcome |
|---|---|
| Non‐Institutional Investors | ACM-200 |
| Qualified Institutional Buyer | ACM-200 |
| Retail individual investor | ACM-200 |
| accredited investor | ACM-200 |
rule acm-68000/in/sebi-suitability-sebi-investment-advisers-regulations-2013-r/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 20 research houses: Ambit Capital Pvt Ltd., Amsec, Avendus Spark, Axis Capital, Bernstein, BNP Paribas Asia, Bonanza, BP Wealth, Dolat Capital Market Ltd., HDFC Research, IIFL (Institutional), Investec, Incred Equities, Jefferies, JP Morgan, JM Financial, Kotak Securities (Institutional Equities), Macquarie, Morgan Stanley and Systematix Group.
| research house | analyst | source · read date |
|---|---|---|
| Ambit Capital Pvt Ltd. | Umesh Laddha | issuer page · 2026-11-12 |
| Amsec | issuer page · 2026-11-12 | |
| Avendus Spark | Dr Harith Ahmed | issuer page · 2026-11-12 |
| Axis Capital | Kunal Randeria | issuer page · 2026-11-12 |
| Bernstein | Nandan Kulkarni | issuer page · 2026-11-12 |
| BNP Paribas Asia | Tausif Shaikh | issuer page · 2026-11-12 |
| Bonanza | issuer page · 2026-11-12 | |
| BP Wealth | Prathamesh Masdekar | issuer page · 2026-11-12 |
| Dolat Capital Market Ltd. | Rashmi Sancheti | issuer page · 2026-11-12 |
| HDFC Research | Mehul Sheth | issuer page · 2026-11-12 |
| IIFL (Institutional) | Rahul Jeewani | issuer page · 2026-11-12 |
| Investec | Anshuman Gupta | issuer page · 2026-11-12 |
| Incred Equities | Ritvik Manglik | issuer page · 2026-11-12 |
| Jefferies | Alok Dalal | issuer page · 2026-11-12 |
| JP Morgan | Bansi Desai | issuer page · 2026-11-12 |
| JM Financial | Amey Chalke | issuer page · 2026-11-12 |
| Kotak Securities (Institutional Equities) | Alankar Garude | issuer page · 2026-11-12 |
| Macquarie | Kunal Dhamesha | issuer page · 2026-11-12 |
| Morgan Stanley | Alka Katiyar | issuer page · 2026-11-12 |
| Systematix Group | Vishal Manchanda | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://nsearchives.nseindia.com/content/equities/EQUITY_L.csv (identity.exchange)
- 10.2
- https://mcp.in-cm-kg.ai/events/XNSE/INE634S01028 (the disclosure lines)
- 10.3
- https://www.nseindia.com/regulations/listing-compliance (the halt flag)
- 10.4
- https://mcp.in-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.5
- https://www.mankindpharma.com/investors-relations/financials/ (coverage)
- 10.6
- https://mcp.in-cm-kg.ai/record/XNSE/INE634S01028 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"INE634S01028"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:8c5190ca4c1216fd.